nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—CYP1B1—Dexamethasone—psoriatic arthritis	0.259	0.279	CbGbCtD
Oxaliplatin—ABCC2—Dexamethasone—psoriatic arthritis	0.136	0.147	CbGbCtD
Oxaliplatin—ABCG2—Dexamethasone—psoriatic arthritis	0.123	0.133	CbGbCtD
Oxaliplatin—CYP1A1—Dexamethasone—psoriatic arthritis	0.114	0.122	CbGbCtD
Oxaliplatin—ABCC2—Methotrexate—psoriatic arthritis	0.11	0.118	CbGbCtD
Oxaliplatin—ABCG2—Methotrexate—psoriatic arthritis	0.099	0.107	CbGbCtD
Oxaliplatin—CYP2E1—Dexamethasone—psoriatic arthritis	0.0879	0.0946	CbGbCtD
Oxaliplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—CARD14—psoriatic arthritis	0.00988	0.139	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL23R—psoriatic arthritis	0.00777	0.109	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL23A—psoriatic arthritis	0.0066	0.0931	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-C—psoriatic arthritis	0.00367	0.0518	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL17A—psoriatic arthritis	0.00309	0.0436	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—IL12B—psoriatic arthritis	0.00287	0.0405	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.00235	0.0332	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-B—psoriatic arthritis	0.00217	0.0306	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-DRB1—psoriatic arthritis	0.00184	0.0259	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—HLA-C—psoriatic arthritis	0.00179	0.0253	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—NOS2—psoriatic arthritis	0.00161	0.0227	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—CRP—psoriatic arthritis	0.00157	0.0221	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—CRP—psoriatic arthritis	0.00137	0.0193	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—CRP—psoriatic arthritis	0.00127	0.018	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-C—psoriatic arthritis	0.0012	0.0169	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—NOS2—psoriatic arthritis	0.00116	0.0164	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.00113	0.0159	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—CRP—psoriatic arthritis	0.00111	0.0157	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—HLA-B—psoriatic arthritis	0.00106	0.015	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.00101	0.0143	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—HLA-DRB1—psoriatic arthritis	0.000898	0.0127	CbGpPWpGaD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TNF—psoriatic arthritis	0.000897	0.0126	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—CRP—psoriatic arthritis	0.000883	0.0125	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—NOD2—psoriatic arthritis	0.000881	0.0124	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—TNF—psoriatic arthritis	0.0008	0.0113	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—MEFV—psoriatic arthritis	0.000765	0.0108	CbGpPWpGaD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—TNF—psoriatic arthritis	0.000709	0.01	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000709	0.00999	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000696	0.00981	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000655	0.00923	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000655	0.00923	CbGpPWpGaD
Oxaliplatin—MPO—Vitamin B12 Metabolism—TNF—psoriatic arthritis	0.000619	0.00872	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.0006	0.00846	CbGpPWpGaD
Oxaliplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—psoriatic arthritis	0.000585	0.00824	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TNF—psoriatic arthritis	0.000577	0.00813	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TNF—psoriatic arthritis	0.000503	0.0071	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.000458	0.00646	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.000444	0.00626	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriatic arthritis	0.000432	0.00609	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—REL—psoriatic arthritis	0.000425	0.006	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—TNF—psoriatic arthritis	0.0004	0.00564	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-C—psoriatic arthritis	0.000391	0.00552	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000315	0.00443	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000315	0.00443	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—NOD2—psoriatic arthritis	0.000288	0.00406	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-B—psoriatic arthritis	0.000231	0.00326	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—NOS2—psoriatic arthritis	0.000228	0.00321	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CRP—psoriatic arthritis	0.000205	0.00288	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-DRB1—psoriatic arthritis	0.000196	0.00276	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000194	0.00273	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000194	0.00273	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000124	0.00174	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000124	0.00174	CbGpPWpGaD
